Clinical trials
Renal Insufficiency, Chronic trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
122 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2009 | 10 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 8 |
| 2017 | 4 |
| 2018 | 9 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 8 |
| 2022 | 12 |
| 2023 | 6 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 71 |
| Recruiting | 15 |
| Unknown status | 14 |
| Active, not recruiting | 12 |
| Terminated | 8 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 16 |
| Bayer | 11 |
| Novartis Pharmaceuticals | 9 |
| AstraZeneca | 8 |
| GlaxoSmithKline | 7 |
| Boehringer Ingelheim | 5 |
| Novo Nordisk A/S | 5 |
| Akebia Therapeutics | 4 |
| Kyunghee University Medical Center | 4 |
| Seoul National University Bundang Hospital | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency, Chronic | 122 |
| Anemia | 17 |
| Kidney Failure, Chronic | 12 |
| Diabetes Mellitus, Type 2 | 10 |
| Glomerulonephritis, IGA | 10 |
| Hypertension | 8 |
| Kidney Diseases | 7 |
| Proteinuria | 7 |
| Glomerulonephritis | 6 |
| Heart Failure | 6 |
Trials
Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.
22 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.